| Literature DB >> 17080769 |
Yinghui Zhou1, John Whitehead, Elisa Bonvini, John W Stevens.
Abstract
In this paper, Bayesian decision procedures are developed for dose-escalation studies based on binary measures of undesirable events and continuous measures of therapeutic benefit. The methods generalize earlier approaches where undesirable events and therapeutic benefit are both binary. A logistic regression model is used to model the binary responses, while a linear regression model is used to model the continuous responses. Prior distributions for the unknown model parameters are suggested. A gain function is discussed and an optional safety constraint is included.Mesh:
Year: 2006 PMID: 17080769 DOI: 10.1002/pst.222
Source DB: PubMed Journal: Pharm Stat ISSN: 1539-1604 Impact factor: 1.894